Newest selected publications
Rowland, R., Pathan, AA., Satti, I., Poulton, ID., Matsumiya, MML., Whittaker, M., (2013) 'Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: A phase i clinical trial'. Human Vaccines and Immunotherapeutics, 9 (1). pp. 50 - 62. ISSN: 2164-5515et al.
Rowland, R., Brittain, N., Poulton, ID., Minassian, AM., Sander, C., Porter, DW., (2012) 'A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity'. Trials in Vaccinology, 1. pp. 27 - 35.Open Access Linket al.
Pathan, AA., Minassian, AM., Sander, CR., Rowland, R., Porter, DW., Poulton, ID., (2012) 'Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults'. Vaccine. ISSN: 0264-410Xet al.
Griffiths, KL., Pathan, AA., Minassian, AM., Sander, CR., Beveridge, NER., Hill, AVS., (2011) 'Th1/Th17 Cell Induction and Corresponding Reduction in ATP Consumption following Vaccination with the Novel Mycobacterium tuberculosis Vaccine MVA85A'. PLoS One, 6 (8). ISSN: 1932-6203 Open Access Linket al.
Beveridge, NER., Price, DA., Casazza, JP., Pathan, AA., Sander, CR., Asher, TE., (2011) 'Correction: Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations'. European Journal of Immunology, 41 (5). pp. 1501 - 1501. ISSN: 0014-2980et al.